Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07478887

Corrie Lipids Program: Optimizing LDL-Cholesterol by Improving Awareness, Access, and Achievement

Led by Johns Hopkins University · Updated on 2026-03-18

1000

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

A

Amgen

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the Corrie Lipids Program, a digital health initiative designed to improve lipid-lowering treatment in adults with uncontrolled LDL cholesterol and high risk of atherosclerotic cardiovascular disease (ASCVD). The study focuses on addressing gaps in care by combining a patient smartphone app, clinician education, and integration into clinical workflows. Researchers will assess its impact on LDL cholesterol goal achievement, app use, prescribing patterns, and monitoring using the RE-AIM framework across multiple centers. Participants will receive access to the Corrie Lipids Digital Health Program, which includes a smartphone app providing LDL cholesterol tracking, medication reminders, and educational content. Clinicians also receive training and coaching to support guideline-based lipid management. The study will track outcomes at 6 and 12 months, including LDL cholesterol goal attainment, app engagement, therapy prescribing rates, and clinician program use. During the study, adults will be monitored for LDL cholesterol levels and app usage. Researchers will collect data on prescriptions, lab tests, and clinician involvement in the program. Participants must have a smartphone and be able to use the app. The study will last at least 12 months, with assessments at 6 and 12 months to understand the program's effectiveness, adoption, and maintenance over time.

CONDITIONS

Brief Title

Impact of the Corrie Lipids Digital Health Program on Lipid Optimization

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Uncontrolled LDL cholesterol according to AHA/ACC guidelines
  • At least one major cardiovascular risk factor, such as high ASCVD risk, known ASCVD, familial hypercholesterolemia, diabetes, or history of statin side effects
  • Has a primary care physician and/or cardiologist who can prescribe lipid therapy
  • Owns a smartphone and agrees to use the digital health app
  • Provided informed consent before starting study activities
Not Eligible

You will not qualify if you...

  • Motor, cognitive, auditory, or visual impairment limiting technology use
  • Does not speak English
  • Malignancy except certain skin cancers or specific carcinoma in situ within the last 5 years
  • Pregnancy, plans to become pregnant or breastfeed, or egg donation plans
  • Likely unable to comply with all study procedures
  • Any other significant disorder or condition posing safety risks or interfering with study participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for eligibility assessment

Implementation

Duration - 12 months

Participants use the Corrie Lipids Digital Health Program app to track LDL cholesterol, receive medication reminders, and access educational materials while clinicians support guideline-directed lipid management.

Participants engage with the app and clinical support throughout the program; follow-up assessments at 6 months and 12 months

Trial Site Locations

Total: 1 location

1

Johns Hopkins University School of Medicine

Baltimore, Maryland, United States, 21287

Actively Recruiting

Loading map...

Research Team

F

Francoise Marvel, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Similar Trials

ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiova...

Cardiovascular Risk

Actively Recruiting

970 locations

Asthma Crisis in Paediatrics: Impact of a Care Pathway in Pr...

Asthma in Children

Actively Recruiting

1 location

Behavioral Economic and Staffing Strategies To Increase Adop...

Implementation Science

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Rationale and design of the Corrie Lipids Program: Impact of a digital health-enabled implementation initiative to improve lipid management.

Allison W Peng, Caroline F Plott, Sohail Zahid...

https://pubmed.ncbi.nlm.nih.gov/41935556